MRNA Trade on Jun 3, 2020 13:58 from beno: Tradervue User Stock Trades.

Fundamentals

N/a

Catalysts / News / Painting the picture

-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
-May 01 2020: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Modernas Vaccine (mRNA-1273)
-May 06 2020: Weak earnings / lags estimates, FDA approves phase 2 of COVID-19 vaccine
-Jun 03 2020: MRNA in top 5 pick for vaccine candidate

Technical Analysis

-SPY pattern: Runner
-Intraday pattern: Runner, Big Pullback
-Levels: 57, 58, 60, 61 ,63

Strategy / Confluence / Sizing Guide / Risk

Strategy: First test long
Confluence: N/a
Strike Zone: 60.40 - 60
Sizing (lots): 2
Risk (stop / Rs): Hold below 60

Review / Lessons Learned

OGT, got to full size then scaled out. I really need to check margin requirements on stocks before playing them because I was out of adds on this trade and wouldn't have been able to add if it dipped to 60, which is an A+ spot to add...

Lessons Learned: CHECK MARGIN, ALWAYS MAKE SURE YOU CAN EMERGENCY LOTS!